KRAS protein expression becomes progressively restricted during embryogenesis and in adulthood
KRAS mutants are common in many cancers and wild-type KRAS is essential in development as its absence causes embryonic lethality. Despite this critical role in development and disease, the normal expression pattern of KRAS protein is still largely unknown at the tissue level due to the lack of valid...
Main Authors: | Marie-Albane Minati, Mohamad Assi, Maxime Libert, Sabine Cordi, Frédéric Lemaigre, Patrick Jacquemin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.995013/full |
Similar Items
-
RETRACTED ARTICLE: KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis
by: Changhwan Yoon, et al.
Published: (2023-07-01) -
A Novel KRAS Antibody Highlights a Regulation Mechanism of Post-Translational Modifications of KRAS during Tumorigenesis
by: Mohamad Assi, et al.
Published: (2020-09-01) -
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
by: Irem Ozkan-Dagliyan, et al.
Published: (2020-06-01) -
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
by: Pierre Dillard, et al.
Published: (2021-01-01) -
Past and Future Strategies to Inhibit Membrane Localization of the KRAS Oncogene
by: Malak Haidar, et al.
Published: (2021-12-01)